{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": true,
    "inverse": false,
    "complex_factors": [
        "Leverage",
        "Swap Usage",
        "Daily Reset Compounding",
        "Counterparty Risk",
        "Collateralised Structure"
    ],
    "classification": "complex",
    "supporting_data": "The product is a collateralised Exchange Traded Product (ETP) that seeks to replicate 3x the daily performance of Barclays PLC via the Solactive Daily Leveraged 3x Long Barclays PLC Index. It uses a swap agreement with Natixis as the swap provider, indicating synthetic replication. The swap is collateralised and backed by assets held at BNY Mellon, but counterparty risk remains a key factor. The product employs daily leverage with a 3x factor and daily reset, causing compounding effects that can significantly deviate returns over periods longer than one day. The risk indicator is at the highest level (7/7), reflecting very high risk and complexity. The product is not UCITS compliant and is explicitly described as not simple and difficult to understand, intended only for investors with specific knowledge and experience. The presence of leverage, synthetic replication via swaps, counterparty risk, and the complex daily compounding mechanism all drive the classification as complex under MiFID II. There is no capital protection, and the product can result in total loss of invested capital. The PRIIPs KID and factsheet confirm the swap usage, leverage, and complexity warnings, reinforcing the complex classification."
}